¼¼°èÀÇ ¿¹¹æ ÀÇ·á ½ÃÀå : ¼­ºñ½º À¯Çüº°, Áúȯ ¿µ¿ªº°, ¿¬·ÉÃþº°, Á¦°ø Çüź°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Preventive Medicine Market, By Service Type, By Disease Area, By Age Group, By Mode of Delivery, By End User, By Geography
»óǰÄÚµå : 1747278
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,151,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,569,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,671,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¿¹¹æ ÀÇ·á ½ÃÀåÀº 2025³â¿¡´Â 4¾ï 3,940¸¸ ´Þ·¯, 2032³â¿¡´Â 6¾ï 3,070¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2032³â CAGR 5.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024 2025³â ½ÃÀå ±Ô¸ð 4¾ï 3,940¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 5.30% 2032³â °¡Ä¡ ¿¹Ãø 6¾ï 3,070¸¸ ´Þ·¯

Áúº´ ¿¹¹æ°ú Á¶±â ¹ß°ßÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼¼°è ¿¹¹æÀÇÇÐ ½ÃÀåÀº ÃÖ±Ù ¸î ³â µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» °ÅµìÇϰí ÀÖ½À´Ï´Ù. ¿¹¹æÀÇÇÐÀº Áúº´ÀÇ ¹ß»ýÀ» ¿¹¹æÇϰí Àü¹ÝÀûÀÎ °Ç°­°ú À£ºùÀ» ÁõÁøÇϱâ À§ÇØ ÃëÇØÁö´Â »çÀü ¿¹¹æÀû Á¶Ä¡¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ÀÌ Á¢±Ù¹ý¿¡´Â °Ç°­°ËÁø, ¿¹¹æÁ¢Á¾, »ýȰ½À°ü °³¼±, À§Çè Æò°¡ µî ´Ù¾çÇÑ Àü·«ÀÌ Æ÷ÇԵ˴ϴÙ. ½ÃÀå ¼ºÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·á ºñ¿ë Àý°¨¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¿©·¯ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ, Áø´Ü µµ±¸ÀÇ ±â¼ú ¹ßÀü°ú Çõ½ÅÀûÀÎ ¿¹¹æ ¿ä¹ýÀÇ °³¹ßÀº ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è Á¤ºÎ¿Í ÀÇ·á ±â°üÀÌ ¿¹¹æ ÀÇ·áÀÇ Àå±âÀûÀÎ ÀÌÁ¡À» ÀνÄÇÔ¿¡ µû¶ó ¿¹¹æ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¿ªÇÐ:.

¼¼°è ¿¹¹æ ÀÇ·á ½ÃÀåÀº ¸î °¡Áö ÁÖ¿ä ÃËÁø¿äÀÎ, ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ¹× ½ÃÀå ±âȸÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ½ÉÇ÷°ü Áúȯ, ´ç´¢º´, ¾Ï°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Áúº´ÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¶±â ¹ß°ß°ú ¿¹¹æ¿¡ ´ëÇÑ Á߿伺ÀÌ °­Á¶µÇ¸é¼­ ¿¹¹æ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ëÀεéÀº ¸¸¼º Áúȯ¿¡ °É¸®±â ½±°í Á¤±âÀûÀÎ ¿¹¹æ ÀÇ·á°¡ ÇÊ¿äÇϱ⠶§¹®¿¡ Àü ¼¼°è ³ëÀÎ Àα¸ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¿¹¹æ ÀÇ·á ±â¼ú°ú °ü·ÃµÈ ³ôÀº ºñ¿ë°ú ÀϺΠÁö¿ª¿¡¼­´Â ¿¹¹æ ÀÇ·áÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³·´Ù´Â Á¡µµ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÀϺΠ±¹°¡¿¡¼­´Â ¿¹¹æÀû ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ Á¦ÇÑÀûÀÎ º¸»ó Á¤Ã¥µµ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµÀü¿¡µµ ºÒ±¸Çϰí, ½ÃÀå¿¡´Â ¼ºÀå°ú Çõ½ÅÀÇ Å« ±âȸ°¡ ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ±â±â ¹× ¿ø°ÝÀÇ·á¿Í °°Àº µðÁöÅÐ Çコ ±â¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿ø°Ý ¸ð´ÏÅ͸µ ¹× °³ÀÎ ¸ÂÃãÇü ¿¹¹æ ÀÇ·á¿¡ »õ·Î¿î ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯ÀüÀÚ °Ë»ç ¹× ¹ÙÀÌ¿À¸¶Ä¿ ºÐ¼®°ú °°Àº ÷´Ü Áø´Ü µµ±¸ÀÇ °³¹ß·Î º¸´Ù Á¤È®ÇÑ À§Çè Æò°¡¿Í Ç¥ÀûÈ­µÈ ¿¹¹æÀû °³ÀÔÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. Á¤ºÎ¿Í ÀÇ·á ±â°üÀÌ ¿¹¹æ ÀǷḦ ¿ì¼±½ÃÇÏ°í ¿¹¹æ ÀÇ·á ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÀÚ¿øÀ» Áö¼ÓÀûÀ¸·Î ÇÒ´çÇÔ¿¡ µû¶ó ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀåÀº Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¿¹¹æ ÀÇ·á ½ÃÀå, ¼­ºñ½º À¯Çüº°, 2020³â-2032³â

Á¦5Àå ¼¼°èÀÇ ¿¹¹æ ÀÇ·á ½ÃÀå, Áúȯ ¿µ¿ªº°, 2020³â-2032³â

Á¦6Àå ¼¼°èÀÇ ¿¹¹æ ÀÇ·á ½ÃÀå, ¿¬·Éº°, 2020³â-2032³â

Á¦7Àå ¼¼°èÀÇ ¿¹¹æ ÀÇ·á ½ÃÀå, Åõ¿© ¹æ¹ýº°, 2020³â-2032³â

Á¦8Àå ¼¼°èÀÇ ¿¹¹æ ÀÇ·á ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020³â-2032³â

Á¦9Àå ¼¼°èÀÇ ¿¹¹æ ÀÇ·á ½ÃÀå, Áö¿ªº°, 2020³â-2032³â, °¡Ä¡

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

Á¦12Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Preventive Medicine Market is estimated to be valued at USD 439.4 Mn in 2025 and is expected to reach USD 630.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 439.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.30% 2032 Value Projection: USD 630.7 Mn

The global preventive medicine market has witnessed significant growth in recent years, driven by the increasing awareness about the importance of disease prevention and early detection. Preventive medicine focuses on the proactive measures taken to prevent the occurrence of diseases and promote overall health and well-being. This approach encompasses a wide range of strategies, including health screenings, vaccinations, lifestyle modifications, and risk assessment. The market's growth can be attributed to several factors, such as the rising prevalence of chronic diseases, the increasing elderly population, and the growing emphasis on reducing healthcare costs. Additionally, technological advancements in diagnostic tools and the development of innovative preventive therapies have further fueled the market's expansion. As governments and healthcare organizations worldwide recognize the long-term benefits of preventive care, the demand for preventive medicine solutions is expected to continue its upward trajectory in the coming years.

Market Dynamic:

The global preventive medicine market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and cancer. The rising burden of these diseases has led to a greater emphasis on early detection and prevention, fueling the demand for preventive medicine solutions. Moreover, the growing elderly population worldwide has further accelerated the market's growth, as older individuals are more susceptible to chronic conditions and require regular preventive care. However, the market also faces certain restraints, such as the high costs associated with preventive medicine technologies and the lack of awareness about the benefits of preventive care in some regions.

Additionally, limited reimbursement policies for preventive services in certain countries may hinder the market's growth. Despite these challenges, the market presents significant opportunities for growth and innovation. The increasing adoption of digital health technologies, such as wearable devices and telemedicine, has opened up new avenues for remote monitoring and personalized preventive care. Furthermore, the development of advanced diagnostic tools, such as genetic testing and biomarker analysis, has enabled more accurate risk assessment and targeted preventive interventions. As governments and healthcare organizations continue to prioritize preventive care and allocate resources towards preventive medicine initiatives, the market is poised for substantial growth in the coming years.

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Preventive Medicine Market, By Service Type, 2020-2032, (USD Mn)

5. Global Preventive Medicine Market, By Disease Area, 2020-2032, (USD Mn)

6. Global Preventive Medicine Market, By Age Group, 2020-2032, (USD Mn)

7. Global Preventive Medicine Market, By Mode of Delivery, 2020-2032, (USD Mn)

8. Global Preventive Medicine Market, By End User, 2020-2032, (USD Mn)

9. Global Preventive Medicine Market, By Region, 2020 - 2032, Value (USD Mn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â